snc logo
AI Search Beta
Search Limit Reached
To ensure smooth performance and fair access for all users, AI searches are limited within a set timeframe. Please try again later.
Companies
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve tooltip-info
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to [email protected]
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    snackbar-icon
    title
    message
    Search Startups

    Tagged as ('orphan-drug') Startups

    Filters
    Clear

    Search by tag (1)

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage 

    Founded 

    From
    To

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees 

    Location 

    Status 
    Processing your search... This may take a moment
    10 Startups 2 In the News 3 Recently Updated
    • Total Funding
      $1.02B
      Raised
      44
      Events
    • Private Funding
      $74.5M
      Raised
      7
      Rounds
    • Public Offerings
      $948.7M
      Raised
      37
      Offerings
    • M&A
      $0
      Raised
      0
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags
    Glion AI Biotherapeutics logo

    Glion AI Biotherapeutics

    STEALTH MODE
    Stealth Mode
    2023 B2B 1-10 Pre-Funding Undisclosed
    generic-drugs
    pharma-companies
    pharmaceuticals
    drug-design
    oncology
    stealthmode
    orphan-drug
    rare-diseases
    amyotrophic-lateral-sclerosis-(als)
    proteins
    degenerative-diseases
    ai-process-optimization
    autoimmune-diseases
    molecular-biology
    Kamada logo

    Kamada

    Public
    Plasma-derived Protein Therapeutics
    1990 B2B 201-500 Public $150M
    therapeutics
    inhalation
    pulmonary
    biopharmaceutical
    diabetes
    critical-care
    respiratory
    pharmaceuticals
    anti-inflammatory
    doctors
    hospitals
    proteins
    orphan-drug
    healthcare-providers
    RedHill Biopharma logo

    RedHill Biopharma

    Public
    Proprietary Drugs for Gastrointestinal and Infectious Diseases
    2009 B2B 11-50 Public $261.25M
    inflammatory-diseases
    crohn's-disease
    biopharmaceutical
    oral-drugs
    medical-products
    gastroenterology
    pharmaceuticals
    oncology
    healthcare-providers
    orphan-drug
    patients
    infectious-disease
    UroGen Pharma logo

    UroGen Pharma

    Public
    Urologic Oncology Therapies
    2004 B2B 201-500 Public $522.2M
    oncology
    drug-delivery
    sustained-release
    urology
    pharmaceuticals
    orphan-drug
    non-surgical
    pharma-companies
    drug-design
    cancer
    Atox Bio logo

    Atox Bio

    PRESUMED INACTIVE
    Immunomodulators for Treatment of Infectious and Inflammatory Diseases
    2003 B2B 11-50 F $64.85M
    inflammatory-diseases
    infectious-disease
    ischemia
    immunology
    orphan-drug
    therapeutics
    critical-care
    pharmaceuticals
    immunotherapy
    patients
    biotechnology
    healthcare-providers
    Can-Fite BioPharma logo

    Can-Fite BioPharma

    Public
    Targeted Drugs for Cancer and Inflammatory Diseases
    1994 B2B 11-50 Public $98.45M
    oncology
    cancer
    inflammatory-diseases
    orphan-drug
    pharmaceuticals
    autoimmune-diseases
    biopharmaceutical
    metabolic-disease
    doctors
    drug-discovery
    pharma-companies
    patients
    biotechnology
    drug-development
    hospitals
    Coronis Neurosciences logo

    Coronis Neurosciences

    PRESUMED INACTIVE
    Neurocognitive and Neurodegenerative Therapies
    2014 B2B 1-10 Seed Undisclosed
    pharmaceuticals
    therapeutics
    biopharmaceutical
    drug-discovery
    neurology
    schizophrenia
    pharma-companies
    autism
    orphan-drug
    patients
    peptides
    treatments
    children
    Processing your search... This may take a moment
    Startup AI Search Beta
    Search notes

    Search Startups

    10 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $1.02B
      Raised
      44
      Events
    • Private Funding
      $74.5M
      Raised
      7
      Rounds
    • Public Offerings
      $948.7M
      Raised
      37
      Offerings
    • M&A
      $0
      Raised
      0
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    Glion AI Biotherapeutics logo
    Raised
    Undisclosed
    Glion AI Biotherapeutics
    Stealth Mode
    Founded:2023
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Kamada logo
    Raised
    $150M
    Kamada
    Public
    Plasma-derived Protein Therapeutics
    Founded:1990
    Business Model:B2B
    Employees:201-500
    Funding Stage:Public
    RedHill Biopharma logo
    Raised
    $261.25M
    RedHill Biopharma
    Public
    Proprietary Drugs for Gastrointestinal and Infectious Diseases
    Founded:2009
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    UroGen Pharma logo
    Raised
    $522.2M
    UroGen Pharma
    Public
    Urologic Oncology Therapies
    Founded:2004
    Business Model:B2B
    Employees:201-500
    Funding Stage:Public
    Atox Bio logo
    Raised
    $64.85M
    Atox Bio
    PRESUMED INACTIVE
    Immunomodulators for Treatment of Infectious and Inflammatory Diseases
    Founded:2003
    Business Model:B2B
    Employees:11-50
    Funding Stage:F
    Can-Fite BioPharma logo
    Raised
    $98.45M
    Can-Fite BioPharma
    Public
    Targeted Drugs for Cancer and Inflammatory Diseases
    Founded:1994
    Business Model:B2B
    Employees:11-50
    Funding Stage:Public
    Coronis Neurosciences logo
    Raised
    Undisclosed
    Coronis Neurosciences
    PRESUMED INACTIVE
    Neurocognitive and Neurodegenerative Therapies
    Founded:2014
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,